Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial. | Sci Rep | 2024 | 39384801 | PubTator, text mining | PubMed |
| Potential Involvements of Cilia-Centrosomal Genes in Primary Congenital Glaucoma. | Int J Mol Sci | 2024 | 39337513 | PubTator, text mining | PubMed |
| Adopting Integrated Bioinformatics and Systems Biology Approaches to Pinpoint the COVID-19 Patients' Risk Factors That Uplift the Onset of Posttraumatic Stress Disorder. | Bioinform Biol Insights | 2024 | 39281421 | PubTator, text mining | PubMed |
| TRPS1, a sensitive marker for different histological and molecular types of breast cancer. | Diagn Pathol | 2024 | 39243111 | PubTator, text mining | PubMed |
| HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis. | Cell Death Dis | 2024 | 39227375 | PubTator, text mining | PubMed |
| Pleiotropy in FOXC1-attributable phenotypes involves altered ciliation and cilia-dependent signaling. | Sci Rep | 2024 | 39217245 | PubTator, text mining | PubMed |
| Suppression of FOXC1 induces pyroptosis of the coronary artery through activation of JAK2. | Atherosclerosis | 2024 | 39182474 | PubTator, text mining | PubMed |
| Conserved role of FOXC1 in TNBC is parallel to FOXA1 in ER+ breast cancer. | iScience | 2024 | 39171293 | PubTator, text mining | PubMed |
| Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications. | Sci Rep | 2024 | 39160196 | PubTator, text mining | PubMed |
| Mutations of CYP1B1 and FOXC1 genes for childhood glaucoma in Japanese individuals. | Jpn J Ophthalmol | 2024 | 39158757 | PubTator, text mining | PubMed |
| Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach. | J Cell Mol Med | 2024 | 39153206 | PubTator, text mining | PubMed |
| Congenital anterior segment ocular disorders: Genotype-phenotype correlations and emerging novel mechanisms. | Prog Retin Eye Res | 2024 | 39097141 | PubTator, text mining | PubMed |
| FOXC1 transcriptionally suppresses ABHD5 to inhibit the progression of renal cell carcinoma through AMPK/mTOR pathway. | Cell Biol Toxicol | 2024 | 39093497 | PubTator, text mining | PubMed |
| Systems biology-based analysis exploring shared biomarkers and pathogenesis of myocardial infarction combined with osteoarthritis. | Front Immunol | 2024 | 39086489 | PubTator, text mining | PubMed |
| Coding, or non-coding, that is the question. | Cell Res | 2024 | 39054345 | PubTator, text mining | PubMed |
| Transcription factor roles in the local adaptation to temperature in the Andean Spiny Toad Rhinella spinulosa. | Sci Rep | 2024 | 38956427 | PubTator, text mining | PubMed |
| RETRACTION: The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma. | Mol Oncol | 2024 | 38949165 | PubTator, text mining | PubMed |
| Functional FOXC1 variants in familial and sporadic atrial septal defect with cellular and animal validation. | Clin Transl Med | 2024 | 38924312 | PubTator, text mining | PubMed |
| Remdesivir ameliorates ulcerative colitis-propelled cell inflammation and pyroptosis in acetic acid rats by restoring SIRT6/FoxC1 pathway. | Int Immunopharmacol | 2024 | 38878489 | PubTator, text mining | PubMed |
| Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma. | Oncotarget | 2024 | 38870080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=11